FDA’s Generic Drug Office Goes On Diet Before Swallowing User Fees
By
Cathy Dombrowski / Email the Author / “The Pink Sheet” Nov. 28, 2011, Vol. 73, No. 48
On Capitol Hill / Word Count: 784 / Article # 00111128021
Executive Summary
Congress sets $52.9 million floor for Office of Generic Drugs in FY 2012, less than in 2011, as part of $3.8 billion FDA funding package. Overall, FDA gets a $50 million boost, but sequestration looms. Appropriations conferees enter the user fee debate, asking how fast FDA approves drug applications.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.